Shocking RNS12 May 2020 17:16
IMHO, I appreciate the Company need the money but this is the least developed of all the COVID stocks. As an investor there is nothing substantial YET to invest in, it is all about potential. Remember this is a buyers market and any of us could get one of the other stocks at a reduced cost in GDR, ODX or SNG to name but a few. Each of those are way further along the line IMO. It may yet be Hemo or one of the others that makes a big break through but the truth is nobody knows which one will.
The one thing that goes against all investable stocks is private pharmaceutical companies whom quite frankly have existing relationships with the British Goverment. (Stabilitech to name but one who have already produced a Zika vaccine pill with Government backing, they are now working on a vaccine pill which obviously would outflank any rival)
The only thing that I find attractive about Hemo is the potential to by in large volumes compared to the others. Thus limiting risk and amplifying potential gains. They have interesting potential and I would buy but only at 6.5p or less. I think it shows the board are not in tune with the mood of the market. Maybe they should try a high street bank.
Please don't listen to these lovesick Hemo bozo's. Hemo is a great company that you may choose to invest in but DYOR and invest for the right reasons.